108 related articles for article (PubMed ID: 32432756)
1. GPAA1 promotes progression of childhood acute lymphoblastic leukemia through regulating c-myc.
Zhang JX; Wang JH; Sun XG; Hou TZ
Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4931-4939. PubMed ID: 32432756
[TBL] [Abstract][Full Text] [Related]
2. Elevated expression of CDT1 in childhood acute lymphoblastic leukemia promotes cell proliferation, invasion and migration through activation of EMT.
Shi HX; Huang SW; Luo WJ; Pan F; Jin HJ; Wei W
J Biol Regul Homeost Agents; 2021 Jul; 35(Special Issue on Internal Medicine n.1):. PubMed ID: 34348833
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of lncRNA FEZF1-AS1 in promoting the occurrence and development of oral squamous cell carcinoma through targeting miR-196a.
Xu L; Hou TJ; Yang P
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6505-6515. PubMed ID: 31378890
[TBL] [Abstract][Full Text] [Related]
4. LINC01551 promotes metastasis of nasopharyngeal carcinoma through targeting microRNA-132-5p.
Xue MY; Cao HX
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3724-3733. PubMed ID: 32329849
[TBL] [Abstract][Full Text] [Related]
5. [Paeoniflorin induces apoptosis and cycle arrest in B-cell acute lymphoblastic leukemia cells by inhibiting SENP1/c-Myc signaling pathway].
Qin X; Chen X; Liu J; Zeng Y; Guo L; Liu WJ
Zhongguo Zhong Yao Za Zhi; 2022 Jun; 47(12):3312-3319. PubMed ID: 35851125
[TBL] [Abstract][Full Text] [Related]
6. MTMR2 promotes the progression of NK/T cell lymphoma by targeting JAK1.
Wang J; He AL; Zhang WG; Cao XM; Chen YX; Liu J; Zhao WH; Yang Y; Wang JL; Liu HL; Ma XR
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):8057-8066. PubMed ID: 32767332
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of LncRNA FOXC2-AC1 promoting lung cancer metastasis by regulating miR-107.
Wu XF; Lu JT; Chen W; Wang N; Meng JC; Zhou YH
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):690-698. PubMed ID: 30720176
[TBL] [Abstract][Full Text] [Related]
8. Tetramethylpyrazine inhibits the proliferation of acute lymphocytic leukemia cell lines via decrease in GSK-3β.
Wang XJ; Xu YH; Yang GC; Chen HX; Zhang P
Oncol Rep; 2015 May; 33(5):2368-74. PubMed ID: 25812605
[TBL] [Abstract][Full Text] [Related]
9. GPAA1 promotes the proliferation, invasion and migration of hepatocellular carcinoma cells by binding to RNA-binding protein SF3B4.
Ge S; Zhang Q; Yang X
Oncol Lett; 2022 May; 23(5):160. PubMed ID: 35399327
[TBL] [Abstract][Full Text] [Related]
10. GPAA1 promotes gastric cancer progression via upregulation of GPI-anchored protein and enhancement of ERBB signalling pathway.
Zhang XX; Ni B; Li Q; Hu LP; Jiang SH; Li RK; Tian GA; Zhu LL; Li J; Zhang XL; Zhang YL; Yang XM; Yang Q; Wang YH; Zhu CC; Zhang ZG
J Exp Clin Cancer Res; 2019 May; 38(1):214. PubMed ID: 31118109
[TBL] [Abstract][Full Text] [Related]
11. CSN6 promotes malignant progression of oral squamous cell carcinoma by down-regulating TIMP-2.
Gao WY; Yang G; Wang J; He JM; Wang P
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5419-5428. PubMed ID: 32495877
[TBL] [Abstract][Full Text] [Related]
12. LncRNA HOXA-AS2 regulates microRNA-216a-5p to promote malignant progression of non-small cell lung cancer.
Cui TJ; Lin GS; Dai YM; Zheng JP; Chen Z; Chen Q; Zheng Y; Lin X
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):264-273. PubMed ID: 31389597
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of glycosyl-phosphatidylinositol anchor attachment protein 1 (GPAA1) is associated with gene amplification in hepatocellular carcinoma.
Ho JC; Cheung ST; Patil M; Chen X; Fan ST
Int J Cancer; 2006 Sep; 119(6):1330-7. PubMed ID: 16642471
[TBL] [Abstract][Full Text] [Related]
14. Enhanced expression and significance of glycosylphosphatidylinositol anchor attachment protein 1 in colorectal cancer.
Chen G; Li SY; Cai HY; Zuo FY
Genet Mol Res; 2014 Jan; 13(1):499-507. PubMed ID: 24535878
[TBL] [Abstract][Full Text] [Related]
15. MIIP inhibits malignant progression of hepatocellular carcinoma through regulating AKT.
Fang J; Chen YL; Yao HB; Peng SS; Yang P; Ding ZY
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2335-2346. PubMed ID: 32196585
[TBL] [Abstract][Full Text] [Related]
16. LncRNA UNC5B-AS1 promotes malignant progression of prostate cancer by competitive binding to caspase-9.
Tan SF; Ni JX; Xiong H
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2271-2280. PubMed ID: 32196578
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-597 inhibits NSCLC progression through negatively regulating CDK2 expression.
Yu DJ; Li YH; Zhong M
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4288-4297. PubMed ID: 32373965
[TBL] [Abstract][Full Text] [Related]
18. LncRNA HOTAIR promotes colon cancer development by down-regulating miRNA-34a.
Peng CL; Zhao XJ; Wei CC; Wu JW
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5752-5761. PubMed ID: 31298326
[TBL] [Abstract][Full Text] [Related]
19. USP3 promotes proliferation of non-small cell lung cancer through regulating RBM4.
Liao XH; Wang Y; Zhong B; Zhu SY
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3143-3151. PubMed ID: 32271432
[TBL] [Abstract][Full Text] [Related]
20. Circ-0003998 promotes cell proliferative ability and invasiveness by binding to miR-197-3p in osteosarcoma.
Wang L; Du ZG; Huang H; Li FS; Li GS; Xu SN
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10638-10646. PubMed ID: 31858530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
